Lactobacillus fermentum CECT5716 – prevention and treatment of lactational mastitis
https://doi.org/10.21518/2079-701X-2019-13-70-72
Abstract
Aim of the study: To present an analysis of the literature data on the role of Lactobacillus fermentum CECT5716 in the prevention and treatment of postpartum lactation complications. Materials and methods: literature sources published in the Pubmed, Scopus database were searched. Results: according to randomized clinical studies, the use of Lactobacillus fermentum CECT5716 in the postnatal period by mothers leads to the correction of breast microbiota by reducing the number of pathogenic bacteria and increasing lactic-acid bacteria, reducing the content of inflammatory factors in breast milk. Conclusion: Lactobacillus fermentum CECT5716 is an effective and safe way to prevent and treat postpartum lactation complications.
About the Author
A. О. Karapetyan
Federal State Budgetary Institution «National Medical Research Center of Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov» of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Anna O. Karapetyan, Doctor of the 1st Maternity Department, Assistant of the Department of Obstetrics and Gynecology of the Department of Professional Education
4, Oparina str., Moscow, 117997
References
1. Lucas A. long-term programming effects of early nutrition – implications for the preterm infant. J Perinatol. 2005;25(Suppl. 2):2–6. doi: 10.1038/sj.jp.7211308.
2. Horta B.L., Bahl R., Martines J.C., Victora C.G. Evidence on the long-term effects of breastfeeding. Geneva: World Health Organization. 2007. Available at: https://apps.who.int/iris/bitstream/handle/10665/43623/9789241595230_eng.pdf;jsessionid=F2A7AC116D622445CC092E46A812A9E6?sequence=1.
3. Victora C.G., Bahl R., Barros A.J.D., Franca G.V.A., Horton S., Krasevec J., Murch S., Sankar M.J., Walker N., Rollins N.C. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387(10017):475490. doi: 10.1016/S0140-6736(15)01024-7.
4. Global strategy for infant and young child feeding. Geneva: World Health Organization. 2003. Available at: https://apps.who.int/iris/bitstream/handle/10665/42590/9241562218.pdf?sequence=1.
5. Kramer M.S., Kakuma R. Optimal duration of exclusive breastfeeding. Cochrane Database Syst Rev. 2012;(8):CD003517. doi: 10.1002/14651858.CD003517.pub2.
6. Ziegler E.E. Human milk-A valuable tool in the early days of life of premature infants. Front Pediatr. 2019;7:266. doi: 10.3389/fped.2019.00266.
7. Zachou G., Armeni E., Lambrinoudaki I. Lactation and maternal cardiovascular disease risk in later life. Maturitas. 2019;122:73-79. doi: 10.1016/j.maturitas.2019.01.007.
8. Borra C., Iacovou M., Sevilla A. New evidence on breastfeeding and postpartum depression: the importance of understanding women’s intentions. Matern Child Health J. 2015;19(4):897-907. doi: 10.1007/s10995-014-1591-z.
9. Islami F., Liu Y., Jemal A., Zhou J., Weiderpass E., Colditz G., Boffetta P., Weiss M. Breastfeeding and breast cancer risk by receptor status – a systematic review and meta-analysis. Ann Oncol. 2015;26(12):2398-2407. doi: 10.1093/annonc/mdv379.
10. Jordan S.J., Na R., Johnatty S.E., Wise L.A., Adami H.O., Brinton L.A., Chen C., Cook L.S., Maso L.D., Vivo I.D., Freudenheim J.L., Friedenreich C.M., La Vecchia C., McCann S.E., Moysich K.B., Lu L., Olson S.H., Palmer J.R., Retruzella S., Pike M.C., Rebbeck T.R., Ricceri F., Risch H.A., Sacerdote C., Setiawan V.W., Sponholtz T.R., Shu X.O., Spurdle A.B., Weiderpass E., Wentzensen N., Yang H.P., Yu H., Webb P.M. Breastfeeding and endometrial cancer risk: an analysis from the epidemiology of endometrial cancer consortium. Obstet Gynecol. 2017;129(6):1059-1067. doi: 10.1097/AOG.0000000000002057.
11. Ballard O., Morrow A.L. Human milk composition. Pediatr Clin North Am. 2013;60(1):49-74. doi: 10.1016/j.pcl.2012.10.002.
12. Urbaniak C., Cummins J., Brackstone M., Macklaim J.M., Gloor G.B., Baban C.K., Scott L., O’Hanlon D.M., Burton J.P., Francis K.P., Tangney M., Reid G. Microbiota of human breast tissue. Applied and Enviromental Microbiology. 2014;80(10):3007-3014. doi: 10.1128/AEM.00242-14.
13. Martin R., Langa S., Reviriego C., Jimenez E., Marin M.L., Xaus J., Fernandez L., Rodriguez J.M. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr. 2003;143(6):754758. doi: 10.1016/j.jpeds.2003.09.028.
14. Togo A., Dufour J.C., Lagier J.C., Dubourg G., Raoult D., Million M. Repertoire of human breast and milk microbiota: a systematic review. Future Microbiol. 2019;14:623-641. doi: 10.2217/fmb-2018-0317.
15. Yu Z., Sun S., Zhang Y. High-risk factors for suppurative mastitis in lactating women. Med Sci Monit. 2018;24:4192-4197. doi: 10.12659/MSM.909394.
16. Contreras G.A., Rodriguez J.M. Mastitis: comparative etiology and epidemiology. J Mammary Gland Biol Neoplasia. 2011;16(4):339-356. doi: 10.1007/s10911-011-9234-0.
17. Maldonado-Lobon J.A., Diaz-Lopez M.A., Carputo R., Duarte P., Diaz-Ropero M.P., Valero A.D., Sanudo A., Sempere L., Ruiz-Lopez M.D., Banuelos O., Fonolla J., Martin M.O. Lactobacillus fermentum CECT 5716 reduces Staphylococcus load in the breastmilk of lactating mothers suffering breast pain: a randomized controlled trial. Breastfeed Med. 2015;10(9):425-432. doi: 10.1089/bfm.2015.0070.
18. Olivares M., Diaz-Ropero M.P., Martin R., Rodriguez J.M., Xaus J. Antimicrobial potential of four Lactobacillus strains isolated from breast milk. J Appl Microbol. 2006;101(1): 72-79. doi: 10.1111/j.1365-2672.2006.02981.x.
19. Diaz-Ropero M.P., Martin R., Sierra S., LaraVilloslada F., Rodriguez J.M., Xaus J., Olivares M. Two Lactobacillus strains isolated from breast milk, differently modulate the immune response. J Appl Microbiol. 2007;102(2):337-343. doi: 10.1111/j.1365-2672.2006.03102.x
20. Hunt K.M., Williams J.E., Shafii B., Hunt M.K., Behre R., Ting R., McGuire M.K., McGuire M.A. Mastitis is associates with increased free fatty acids, somatic cell count, and interleukin-8 concentrations in human milk. Breastfeed Med. 2013;8(1):105-110. doi: 10.1089/bfm.2011.0141.
21. Bond D.M., Morris J.M., Nassar N. Study protocol: evaluation of the probiotic Lactobacillus Fermentum CECT 5716 for the prevention of mastitis in breastfeeding women: a randomized controlled trial. BMC Pregnancy Childbirth. 2017;17(1):148. doi: 10.1186/s12884-017-1330-8.
22. Gil-Campos M., Lopez M.A., Rodriquez-Benitez M.V., Romero J., Roncero I., Linares M.D., Maldonado J., Lopez-Huertas E., Berwind R., Ritzenthaler K.L., Navas V., Sierra C., Sempere L., Geelings A., Maldonado-Lobon J.A., Valero A.D., Lara-Villoslada F., Olivares M. Lactobacillus Fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: a randomized controlled trial. Pharmacol Res. 2012;65(2):231-238. doi: 10.1016/j.phrs.2011.11.016.
23. Maldonado J., Canabate F., Sempere L., Vela F., Sanchez A.R., Narbona E., Lopez-Huertas E., Geeling A., Valero A.D., Olivares M., LaraVilloslada F. Human milk probiotic Lactobacillus Fermentum CECT 5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants. J Pediatr Gastroenterol Nutr. 2012;54(1):55-61. doi: 10.1097/MPG.0b013e3182333f18.
Review
For citations:
Karapetyan AО. Lactobacillus fermentum CECT5716 – prevention and treatment of lactational mastitis. Meditsinskiy sovet = Medical Council. 2019;(13):70-72. (In Russ.) https://doi.org/10.21518/2079-701X-2019-13-70-72
Views:
1483
Email this article 